State Ledger
Company profile

SOLIGENIX, INC. CIK 812796

Ticker
SNGX (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Princeton, NJ 08540
Fiscal year end
2025 (FY)
Market Data
Close
$0.35
Change
+$0.01
Change %
1.71%
Volume
810

SNGX · trading date Oct 12, 2026 · previous close $0.35 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$11.08M
Total assets
$9.24M
Total liabilities
$3.94M
Stockholders' equity
$5.29M
Cash & equivalents
$7.94M
Operating income
-$11.85M
Operating cash flow
-$10.27M
Capital expenditures
$5.9K

Fiscal year 2025, via 10-K filed 2026-03-31. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$10.27M
Free cash flow margin
—
Liabilities / assets
42.7%
Equity / assets
57.3%
CapEx / revenue
—
Operating cash flow / net income
0.93×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$11.08M $9.24M $3.94M $5.29M
2024 $119.4K -$8.27M $8.97M $4.85M $4.12M
2023 $839.4K -$6.14M $9.80M $7.27M $2.52M
2022 $948.9K -$13.80M $14.28M $16.75M -$2.47M
2021 $824.3K -$12.55M $26.87M $16.15M $10.72M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-18
Financials filed via
Form 10-K
filed 2026-03-31

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Princeton, NJ 08540
29 EMMONS DRIVE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:39 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to New Jersey — Public Companies